Stay updated with breaking news from Auguste Deter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more
Ironically, the first person to be diagnosed with what is now Alzheimer’s disease was missing its major risk factor. When she first began showing symptoms of dementia in 1901, Auguste Deter was not particularly old. Despite Deter’s case, aging is the largest risk factor for developing Alzheimer’s, by a large margin. But “geroscience has not been translated into drugs for Alzheimer’s disease,” Howard Fillit, Alzheimer’s Drug Discovery Foundation co-founder and chief scientific officer, told BioWorld. “We’re just starting to see that cross-fertilization now.” This first artic...
In a fraternity where terminologies, nomenclatures, and eponyms shape and reshape their identities like a spy on a run, this newly born medical coinage should not surprise us. Except that it has less to do...
Medical texts from 2,500 years ago rarely mention severe memory loss, suggesting today’s widespread dementia stems from modern environments and lifestyles.
UAB is looking to enroll people into a new Alzheimer's study. It's called the AHEAD study.Recently, the food and drug administration approved a new alzheimer’s